Trial: 201705025

PNOC 007 – H3.3K27M Specific Peptide Vaccine Combined with poly-ICLC with or without PD-1 inhibition using Nivolumab for the Treatment of Newly Diagnosed HLA-A2 (02:01)+ H3.3K27M Positive Diffuse Intrinsic Pontine Glioma (DIPG) and Newly Diagnosed HLA-A2 (02:01)+ H3.3K27M Positive Gliomas

Phase

I

Principal Investigator

Cluster, Andrew

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov